Premium
The rapidly evolving landscape of biomarker testing in non–small cell lung cancer
Author(s) -
VanderLaan Paul A.,
Rangachari Deepa,
Costa Daniel B.
Publication year - 2021
Publication title -
cancer cytopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.29
H-Index - 57
eISSN - 1934-6638
pISSN - 1934-662X
DOI - 10.1002/cncy.22334
Subject(s) - medicine , lung cancer , ros1 , crizotinib , cancer , oncology , clinical trial , adenocarcinoma , guideline , biomarker , drug development , targeted therapy , intensive care medicine , pathology , drug , pharmacology , biochemistry , chemistry , malignant pleural effusion